. 2022 Nov 7;27(1):249–258. doi: 10.1080/13510002.2022.2139947

Table 3.

Treatment of CKD rat model with ZnO-NP and SPL results in down-regulation of oxidative stress and enhanced antioxidants.

Groups	Control	CKD	SPL	ZnO-NPs	SPL + ZnO-NPs
GSH (mmol/g)	9.4 ± 2.5	2.5 ± 0.73^a	4.44 ± 1.41^a	5.78 ± 1.14^ab	8.39 ± 1.72^bc
SOD (U/g)	324.7 ± 41.21	121.6 ± 37.2^a	217.03 ± 34.7^ab	260.14 ± 33.8^ab	297.6 ± 21.27^bc
CAT (U/g)	8 ± 3.32	1.68 ± 0.51^a	5.25 ± 1.32^ab	6.03 ± 1.21^ab	7.36 ± 2.11^b
MDA (nmol/g)	11.58 ± 3.33	49.77 ± 11.05^a	32.37 ± 5.96^ab	24 ± 5.65^ab	15.9 ± 4.12^bc

Notes: Significant difference compared to corresponding ^acontrol group, ^bCKD group, ^cSPL group, ^dZnO-NPs group at p < 0.05 by ANOVA and Tukey test.